Back

Session 10: Liver Metastases

ON-DEMAND

Panelist(s)

Kamran Ahrar, MD, MBA

University of Texas M. D. Anderson Cancer Center, United States
Rony Avritscher, MD

University of Texas MD Anderson Cancer Center, United States
Daniel Brown, MD

Professor of Radiology
Vanderbilt University Medical Center
Vanderbilt University School of Medicine, United States
Sanjeeva Kalva, MD, FSIR, FCIRSE

Harvard Medical School, United States

Speaker(s)

Nadine Abi-Jaoudeh, MD

University of California, Irvine, United States
Kamran Ahrar, MD, MBA

University of Texas M. D. Anderson Cancer Center, United States
Rony Avritscher, MD

University of Texas MD Anderson Cancer Center, United States
Daniel Brown, MD

Professor of Radiology
Vanderbilt University Medical Center
Vanderbilt University School of Medicine, United States
Boris Guiu, MD, PhD

St-Eloi University Hospital
St-Eloi University Hospital, France
Frank Wacker

Hannover Medical School, Germany

Presentations:

Ablation for Colorectal Liver Metastases: What is the Evidence?
Kamran Ahrar, MD, MBA
mCRC: Data Driven Y90 for 1st Line, 2nd Line and Salvage
Daniel B. Brown, MD – Vanderbilt University Medical Center
DEBIRI for mCRC: Is it Finally Standardized?
Nadine Abi-Jaoudeh, MD
FLR Hypertrophy: New Approaches to Assure Success
Boris Guiu, MD, PhD – St-Eloi University Hospital
Role of Liver Directed Therapy for mNET and Intra-arterial Therapy of Choice
Rony Avritscher, MD
PHP Chemosaturation: Ocular Melanoma Mets and Beyond
Frank K. Wacker
Is SBRT Competing With Your Ablation Program for CRC Liver Metastases?
Kamran Ahrar, MD, MBA; Rony Avritscher, MD; Daniel B. Brown, MD – Vanderbilt University Medical Center; Sanjeeva P. Kalva, MD, FSIR, FCIRSE
Is First-line Y90 Dead, or What Do We Need to Design a Positive Study?
Kamran Ahrar, MD, MBA; Rony Avritscher, MD; Daniel B. Brown, MD – Vanderbilt University Medical Center; Sanjeeva P. Kalva, MD, FSIR, FCIRSE
Why is DEBIRI Not as Utilized as Y90, and Why Has No One Confirmed Fiorentini's Ph2 Results?
Kamran Ahrar, MD, MBA; Rony Avritscher, MD; Daniel B. Brown, MD – Vanderbilt University Medical Center; Sanjeeva P. Kalva, MD, FSIR, FCIRSE
What Adjunctive Procedures Do People Use to Boost Hypertrophy?
Kamran Ahrar, MD, MBA; Rony Avritscher, MD; Daniel B. Brown, MD – Vanderbilt University Medical Center; Sanjeeva P. Kalva, MD, FSIR, FCIRSE
In the Era of PRRT, Which Patients Should We Still Advocate for Locoregional Therapy?
Kamran Ahrar, MD, MBA; Rony Avritscher, MD; Daniel B. Brown, MD – Vanderbilt University Medical Center; Sanjeeva P. Kalva, MD, FSIR, FCIRSE
How Can We Make This Technology Accessible?
Kamran Ahrar, MD, MBA; Rony Avritscher, MD; Daniel B. Brown, MD – Vanderbilt University Medical Center; Sanjeeva P. Kalva, MD, FSIR, FCIRSE